Evaluation of the benefit of rivaroxaban on VOYAGER PAD primary composite of limb, heart and brain outcomes using the global rank and win ratio methods
29 August 2022 (14:40 - 14:50)
Organised by:
About the speaker
University of Colorado Anschutz Medical Campus, Aurora (United States of America)
5 More presentations in this session
Mrs M. Soegaard (Aalborg, DK)
Doctor G. Goudot (Paris, FR)
Doctor A. Guedon (Paris, FR)
Doctor N. Nakamura (Isehara, JP)
Access the full session
The Event
ESC Congress 2022
29 August 2022
14:40 CET
